BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Cedilla Therapeutics

Cedilla Therapeutics logo

Founded
2018
Geography
United States of America based
Funding
$56.200 M

Cedilla is harnessing intrinsic protein stability mechanisms to broaden the reach of small molecule therapeutics. They work on cancer and other diseases caused by protein dysregulation.

Technologies

Protein Degraders Startups  


Posts Mentioning This Company

R&D Platform

-


Pipelines

Transcription Factor Precision Therapeutic
Preclinical  |  Visit website

Cedilla is developing novel small-molecule therapeutics directed to unrecognized allosteric binding sites, providing new ways to target key cancer drivers and treat life threatening diseases.

Products

 

Services

No services posted yet